Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 2
1981 4
1982 1
1983 1
1984 4
1985 1
1986 2
1987 3
1988 2
1989 2
1990 6
1991 7
1992 4
1993 2
1994 5
1995 3
1996 4
1997 4
1998 5
1999 2
2000 4
2001 3
2003 1
2004 5
2005 2
2006 4
2007 4
2008 3
2009 3
2010 6
2011 6
2012 8
2013 7
2014 6
2015 15
2016 7
2017 7
2018 7
2019 8
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

173 results
Results by year
Filters applied: . Clear all
Page 1
The Role of miR-21 in Cancer.
Pfeffer SR, Yang CH, Pfeffer LM. Pfeffer SR, et al. Among authors: pfeffer lm. Drug Dev Res. 2015 Sep;76(6):270-7. doi: 10.1002/ddr.21257. Epub 2015 Jun 16. Drug Dev Res. 2015. PMID: 26082192 Review.
Orally Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer.
Ponnusamy S, He Y, Hwang DJ, Thiyagarajan T, Houtman R, Bocharova V, Sumpter BG, Fernandez E, Johnson D, Du Z, Pfeffer LM, Getzenberg RH, McEwan IJ, Miller DD, Narayanan R. Ponnusamy S, et al. Among authors: pfeffer lm. Clin Cancer Res. 2019 Nov 15;25(22):6764-6780. doi: 10.1158/1078-0432.CCR-19-1458. Epub 2019 Sep 3. Clin Cancer Res. 2019. PMID: 31481513 Free article.
The Type I IFN-Induced miRNA, miR-21.
Yang CH, Li K, Pfeffer SR, Pfeffer LM. Yang CH, et al. Among authors: pfeffer lm. Pharmaceuticals (Basel). 2015 Nov 25;8(4):836-47. doi: 10.3390/ph8040836. Pharmaceuticals (Basel). 2015. PMID: 26610525 Free PMC article. Review.
173 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page